Melanotan 2 (MT-2) Peptide 10mg

Melanotan 2 (MT-2) Peptide 10mg: Product Overview

Melanotan 2 (MT-2) Peptide 10mg, also known as Melanotan II, is a synthetic cyclic heptapeptide developed as an analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It belongs to the melanocortin peptide family and has been investigated for its interaction with receptors involved in skin pigmentation and other physiological signaling pathways.

Melanotan II is distinct from Melanotan I (Afamelanotide) and PT-141 (Bremelanotide), although these compounds share a research background involving the melanocortin receptor system. The 10mg designation identifies the stated peptide quantity in this product listing.

Melanotan II 10mg Product Specifications

• Product Name: Melanotan 2 Peptide 10mg
• Alternative Names: Melanotan II, MT-2, MT-II
• Peptide Type: Synthetic cyclic heptapeptide
• Peptide Family: Melanocortin peptides
• Listed Quantity: 10mg
• CAS Number: 121062-08-6 (free peptide)
• Molecular Formula: C50H69N15O9 (free peptide)
• Molecular Weight: Approximately 1024.2 g/mol (free peptide)
• Category: Research Peptides

The molecular information above describes Melanotan II in its free-peptide form. Acetate salt preparations can have different molecular specifications. Confirm the actual chemical form through product-specific documentation.

What Is Melanotan 2 (MT-2)?

Melanotan 2 is a synthetic analog of the naturally occurring alpha-MSH peptide. Alpha-MSH participates in melanocortin signaling, including biological processes associated with melanin production and pigmentation.

MT-2 was developed to investigate melanocortin receptor activation using a modified cyclic peptide structure. The compound has been examined in experimental studies addressing pigmentation pathways, receptor signaling and additional physiological responses.

Melanotan II Mechanism of Action

Melanotan II acts as a melanocortin receptor agonist. Its activity includes receptor pathways associated with melanin synthesis and pigmentation regulation.

Activation of melanocortin-1 receptors (MC1R) in melanocytes can stimulate biological processes involved in melanin production. Other melanocortin receptor subtypes participate in central nervous system signaling and metabolic regulation.

The compound's biological activity is broader than pigmentation alone. However, experimental findings do not establish the safety or effectiveness of an independently supplied MT-2 peptide product for human use.

Melanotan 2 Peptide Research

Scientific investigations involving Melanotan II have examined melanocortin receptor pharmacology, pigmentation responses and interactions with neurological signaling pathways.

Research has also explored the relationship between melanocortin activity and physiological processes involving appetite and sexual response. Findings depend on the particular experimental model, formulation and study conditions.

Melanotan II is not an established treatment for cosmetic tanning. Its clinical safety profile remains insufficiently characterized, and reported adverse effects include nausea, flushing and changes in pigmented skin lesions.

Melanotan 2 vs PT-141: Key Differences

Melanotan II and PT-141 (Bremelanotide) are related synthetic melanocortin peptides, but they are not identical compounds.

• Melanotan II (MT-2): Investigated for pigmentation-related activity and broader melanocortin receptor signaling.
• PT-141 (Bremelanotide): Developed primarily through research involving melanocortin pathways associated with sexual response.
• Melanotan I (Afamelanotide): A different melanocortin analog with a distinct structure and clinical development history.

These compounds should be evaluated individually. Their different molecular structures, pharmacological profiles and research findings should not be treated as interchangeable.

Melanotan II 10mg Packaging and Documentation

The Melanotan 2 Peptide 10mg product listing identifies a stated quantity of MT-2 peptide material. Product identification should be based on the supplied label, original packaging photographs and available batch-specific documentation.

Relevant details include the declared peptide identity, chemical form, quantity, purity information when available and formulation-specific storage instructions. General molecular reference data does not verify the composition or quality of an individual supplied batch.